Regulatory News
Tuesday, June 14, 2016
UPDATE 1-Novo diabetes drug cuts heart risks by 13 pct in trial
* Some investors had been hoping for bigger benefit
(Adds reaction from executive and analyst)
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment